Researchers from UCT’s Drug Discovery and Development Centre, H3D, have identified a potent new anti-malarial development candidate with potential for both treatment and prevention of malaria.
Peter Cheuka, a PhD student in the Chibale research group, attended the Gordon Research Conference in New London, NH as well as the 2016 EFMC International Symposium on Medicinal Chemistry in Manchester, UK.
MSc students, Jessica Akester and Chyanne Abbott, attended and presented posters at the ICPAC 2016 conference where Prof. Kelly Chibale was a keynote speaker.
Dr Mathew Njoroge, a postdoctoral Fellow in the Chibale group attended the 11th ISSX Meeting
The third H3D Symposium of the University of Cape Town’s Drug Discovery and Development Centre (H3D) was held 15 - 18 November 2016 at the Goudini Spa, South Africa. The theme of this Symposium was ‘Malaria, TB and Neglected Tropical Diseases: Progress in Drug Discovery and Development.’
Around 150 students, academics and delegates from the pharmaceutical industry, both in Africa and internationally, attended the Symposium, generously sponsored by International institutions.
See the website for more information.
Panel discussion attended by Prof. Kelly Chibale at the World Health Assembly in Geneva (Switzerland) for a conversation with product developers on developing and scaling essential health technologies.